[Valve replacement for congenital valvular disease].
Among 365 cases of mitral and aortic valve replacement (MVR, AVR) done in our institute during the period between 1968 and 1983, there were 20 congenital cases (5.5%), who were pointed out to have valvular disease since birth or early childhood and had no evident history of infectious disease. Mean ages at operation of MVR and AVR groups were 5.6 +/- 3.6 and 22.4 +/- 6.0 years respectively. Predominant pathology of mitral valve was regurgitation in 9 and stenosis in 2 cases. Seven cases were associated with other cardiac anomalies. Cumulative follow-up period was 34.3 patient-years (p-y). There were 3 late deaths resulted from xenograft calcification. In AVR group, predominant pathology of the valve was regurgitation in 8 cases and stenoregurgitation in one case. All cases were associated with other cardiac anomalies. There were 2 late deaths within the cumulative follow-up period of 39.5 p-y. Cumulative survival rates at 15 years, both in MVR and AVR groups were lower in congenital group than in the group of acquired disease. The incidences of prosthesis malfunction, prosthesis related complication and late death in the both MVR and AVR groups were higher in congenital group, when compared to that in the group of acquired disease.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006349:Heart Valve Diseases / Q000151:congenital / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006801:Humans; D007223:Infant; D008297:Male